Results 151 to 160 of about 24,287 (262)

Luteinizing hormone activates the Hippo pathway to promote progesterone synthesis in bovine luteal cells. [PDF]

Cell Commun Signal
Tamanaeifar F, Owolabi BA, Monaco CF, Moses RM, Castillo AC, Cupp AS, Davis JS, Plewes MR.   +7 more
europepmc   +1 more source

The Affective Afterlife of the “Smelly Immigrant” Trope: Contested Scents, “Race,” and Olfactory Contact Zones in Berlin

City &Society, Volume 38, Issue 3, December 2026.
ABSTRACT This paper proposes the notion of “olfactory contact zones” to investigate the role of odors and scents and the affects they give rise to in Berlin's urban publics. Drawing on the notion of the “afterlife” of racialised violence, it shows how tropes of the “smelly immigrant,” anchored in European antisemitism and colonial history, live on ...
Claudia Liebelt
wiley   +1 more source

Research on the Hippo Pathway in Cancer. [PDF]

Cells
Dang F, Dai S, Zhao T, Zhang R, Chen L, Zhao Y.   +5 more
europepmc   +1 more source

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients

International Journal of Cancer, Volume 159, Issue 7, Page 1829-1843, 1 October 2026.
Long non‐coding RNAs (lncRNAs) signatures are promising cancer biomarkers, since their dysregulation in tumors is reflected in body fluids. In this study, next‐generation sequencing, bioinformatics, and gene expression data were combined to investigate an lncRNA signature linked specifically to the cancer‐promoting YAP in several cancer types ...
Fabian Rose, Nada El‐Ekiaby, Lilija Wehling, Sofia Maria Elisabeth Weiler, Jennifer Schmitt, Marcell Tóth, Fabiola Pedrini, Amruta Damle‐Vartak, Carsten Sticht, Rossella Pellegrino, Injie Omar Fawzy, Merna Hatem Mohamed Hamad, Mohamed Negm, Dina Omar, Hossam Eldeen Soliman, Gamal Esmat, Thomas Longerich, Thomas Illig, Bruno Christian Köhler, Anna Saborowski, Heike Bantel, Arndt Vogel, Peter Schirmacher, Ahmed Ihab Abdelaziz, Kai Breuhahn   +24 more
wiley   +1 more source

EZH2 blockade reverses doxorubicin resistance by inducing metabolic vulnerability and enhancing DNA damage in breast cancer. [PDF]

Front Pharmacol
Wang X, Ding Y, Mai Y, Li R, Shao X, Chen W, Li Y, Liu L, Wang H, Liu K, Niu Y, Li J, Xu G, Zhao Y.   +13 more
europepmc   +1 more source

Changing a Winning Team—Replacement of Brominated Flame Retardant and Antimony Trioxide in Acrylonitrile–Butadiene–Styrene

Journal of Applied Polymer Science, Volume 143, Issue 35, September 15, 2026.
This comprehensive study investigates reducing the amount of brominated flame retardant (Br) and/or antimony trioxide (ATO) in acrylonitrile–butadiene–styrene. Therefore, condensed‐phase flame‐retardant mechanisms are introduced into the flame‐inhibition system.
Sebastian M. Goller, Bernhard Schartel, Simone Krüger   +2 more
wiley   +1 more source

Mechanobiology of the Hippo-YAP Signaling Network. [PDF]

Cold Spring Harb Perspect Biol
Tripathi BK, Irvine KD.
europepmc   +1 more source

Surviving the Nucleus Pulposus Desert: Next‐Generation Strategies for Intervertebral Disc Cell Therapy

JOR SPINE, Volume 9, Issue 3, September 2026.
ABSTRACTBackgroundLow back pain remains the leading cause of disability worldwide, with intervertebral disc degeneration representing a major biological contributor. Although cell‐based therapies have shown promise in preclinical models, clinical translation has yielded modest and inconsistent outcomes.
Tynhinane Hamidouche, Namdev More, Tiffany Lee, Mia Orr, Anne Camus, Devina Purmessur, Sarah E. Gulbrand, Nadeen O. Chahine, Lara Silverman, Dmitriy Sheyn   +9 more
wiley   +1 more source

Hemodynamics and matrix stiffness shape the pathogenicity of SPP1⁺ macrophages. [PDF]

Front Immunol
Zhang H, Han J, Zhu S, Yi M, Fan K, Chang R, Shi Y, Dong H.   +7 more
europepmc   +1 more source

Cyclins and Cyclin‐Dependent Kinases: Structure, Biological Functions, and Innovative Targeting Strategies in Cancer

MedComm, Volume 7, Issue 9, September 2026.
This work synthesizes recent insights into the pathological roles of cyclins and cyclin‐dependent kinases (CDKs) across human cancers, highlights state‐of‐the‐art innovative approaches (especially targeted degradation and redistribution of CDK/cyclin proteins) for cancer therapy, and outlines future directions for CDK/cyclin‐related biomedical research.
Suya Zheng, Zhipeng Shen, Yuanfang Wu, Xingze Huang, Zhongyuan Zhang, Jiangyu Liu, Qichun Wei, Wenhao Chen, Ye Chen, Liang Xu   +9 more
wiley   +1 more source